Peter J Richardson

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Peter J Richardson, Daniel P Smith, Alex de Giorgio, Xenia Snetkov, Joshua Almond-Thynne, Sara Cronin, Richard J Mead, Christopher J McDermott, Pamela J Shaw
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis. Translational neurodegeneration 12 (1) (2023)
Peter J Richardson, Bruce W S Robinson, Daniel P Smith, Justin Stebbing
The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19. Vaccines 10 (6) (2022)
Diana M Carvalho, Peter J Richardson, Nagore Olaciregui, Reda Stankunaite, Cinzia Lavarino, Valeria Molinari, Elizabeth A Corley, Daniel P Smith, Ruth Ruddle, Adam Donovan, Akos Pal, Florence I Raynaud, Sara Temelso, Alan Mackay, John P Overington, Anne Phelan, David Sheppard, Andrew Mackinnon, Bassel Zebian, Safa Al-Sarraj, Ashirwad Merve, Jeremy Pryce, Jacques Grill, Michael Hubank, Ofelia Cruz Martinez, Andres Morales La Madrid, Sabine Mueller, Angel Montero Carcaboso, Fernando Carceller, Chris Jones
Repurposing vandetanib plus everolimus for the treatment of ACVR1-mutant diffuse intrinsic pontine glioma. Cancer discovery (2021)

Peter J Richardson.css-eqlu8i{font-size:small;padding-left:4px;}